NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,454,850 | – | 95,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 16,245,817 | $247,749,000 | 45.93% |
Ponoi II Management, LLC | 1,298,908 | $19,808,000 | 43.96% |
RHO CAPITAL PARTNERS INC | 3,766,666 | $57,442,000 | 39.74% |
Ponoi Management, LLC | 1,298,908 | $19,808,000 | 25.71% |
Euclidean Capital LLC | 746,674 | $11,387,000 | 6.62% |
StepStone Group LP | 1,573,357 | $23,994,000 | 1.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,494 | $3,058,000 | 1.26% |
First Light Asset Management, LLC | 816,653 | $12,454,000 | 1.10% |
BVF INC/IL | 955,000 | $14,564,000 | 0.58% |
HighVista Strategies LLC | 46,243 | $705,000 | 0.45% |